Vivo Bio Tech Ltd.
Fundamentals
- Market cap
- ₹51.04 cr
- ROE
- 9.35%
- Debt / equity
- 0.69
- 52-week range
- 20.35 — 43.35
Company snapshot
Vivo Bio Tech Ltd.
Pharmaceuticals
₹52 cr
Latest quarter · Jun 2026
Sales₹14 cr
Net profit₹0 cr
Op. margin+35.4%
EPS₹0.08
Strength & growth
Debt / equity0.69×
Current ratio1.51×
Sales CAGR+6.4%
EPS CAGR+7.6%
The timeline — 5 notes on Vivo Bio Tech Ltd.
July 2026
- 13 Jul 26 · 7:51 PM IST Brief Brief · Earnings · Micro cap
Vivo Bio Tech profit plunges 86% despite 14% revenue growth
Net profit fell to ₹1.88 crore from ₹13.37 crore a year ago as employee costs and depreciation surged. The board approved the unaudited results on July 13.
- 13 Jul 26 · 7:43 PM IST Brief Brief · Earnings · Micro cap
Vivo Bio Tech profit slumps 86% even as revenue climbs 14%
Employee costs and depreciation erode margins in June quarter; net profit at ₹1.88 crore.
May 2026
- 30 May 26 · 10:46 PM IST Brief Brief · Earnings · Micro cap
Vivo Bio Tech posts ₹5.44 cr Q4 loss; auditor flags ₹4.19 cr in overdue dues
A ₹6.97 cr deferred tax charge swung the quarter to a loss. The full year turned red too, and the auditor is chasing ₹4.19 cr in unpaid statutory dues.
- 25 May 26 · 5:39 PM IST Lead Lead · Micro cap
Vivo Bio Tech to consider merging a resort company into itself
The nano-cap contract research outfit will weigh a deal with Shri Shri Resorts alongside its Q4 results on May 29.